Table 1:

Patient demographics and comorbidities

Patient Characteristics (No.) (%)aIOCM (n = 4042)LOCM (n = 38,130)
Age (yr)
 Mean (SD)69.1(13.8)67.2(14.6)
Sex
 Male2083(51.5)20,140(52.8)
 Female1959(48.5)17,988(47.2)
Race
 White3058(75.7)28,995(76.0)
 Black501(12.4)4652(12.2)
 Other483(11.9)4483(11.8)
Insurance
 Commercial174(4.3)2020(5.3)
 Medicare2619(64.8)22,347(58.6)
 Medicaid334(8.3)3907(10.2)
 Managed care670(16.6)6726(17.6)
 Other245(6.1)3130(8.2)
Elixhauser Comorbidity Index scoreb 
 Mean (SD)4.6(2.2)4.5(2.2)
Chronic kidney disease    
 Stage 16(0.1)34(0.1)
 Stage 233(0.8)319(0.8)
 Stage 3363(9.0)2067(5.4)
 Stage 481(2.0)293(0.8)
 Unspecified274(6.8)1574(4.1)
Record of acute kidney injury
 On admission405(10.0)2929(7.7)
 In previous admission37(0.9)321(0.8)
  • a All values reported as No. (%) unless otherwise noted.

  • b The Elixhauser Comorbidity Index score is calculated using 31 categories of comorbidities associated with mortality and is based on International Classification of Diseases 9 and 10 codes. Each comorbidity category is dichotomous and includes heart failure, cardiac arrhythmia, hypertension, diabetes mellitus, obesity, and so forth.